~~<i id='385C9FBD3B'><strike id='385C9FBD3B'><tt id='385C9FBD3B'><pre id='385C9FBD3B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：Wikipedia 2025-09-30 22:08:54 - browse：89383

A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron.

“It has been exciting to be involved,” Gorham wrote.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

explore

knowledge

leisure time

explore

knowledge

focus

KristofferTripplaar/APEventually,theluckiestcompaniesgettodealwithaveryparticularproblem:whattodowhe

WSS

Cassava reveals details — and problems — with Alzheimer's study

Readout Newsletter: XBI biotech index, Akero Therapeutics

Maker of FluMist seeks to allow at

Tome Biosciences co

Senate panel to vote on hospitals, PBMs, prisoner care

Senate panel to vote on hospitals, PBMs, prisoner care

focus

explore

explore

Sports medicine is finally prioritizing gender equality

Hospitals warn Medicare's drug payment fix is ‘unlawful’

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: New research from Sanofi, Regeneron, etc.

What does generative AI mean for health care? We asked experts

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Guidelines to prevent youth baseball injuries need more muscle

Meta's Zuckerberg and Chan on track to put $50 billion into science

Medicare details structure of new drug price negotiation program

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

knowledge

Biden's order seeks to regulate AI risk without stifling innovation

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Meta's Zuckerberg and Chan on track to put $50 billion into science

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Traditional Chinese medicine benefits explored in new JAMA study

leisure time

explore

knowledge

focus